Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

Stiffness, aches or pain that sometimes radiates down to the legs—most backs protest at least once in a lifetime. Movement is ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.

The card features unlimited 2% cash back on all purchases, a sign-up bonus and a 0% intro APR promotion. When it comes to flat-rate cash-back cards, it's hard to beat 2% back, especially when the ...